Targeting redox regulation to treat substance use disorder using N‐acetylcysteine

The European Journal of Neuroscience
Jacqueline S WomersleyJoachim D Uys

Abstract

Substance use disorder (SUD) is a chronic relapsing disorder characterized by transitioning from acute drug reward to compulsive drug use. Despite the heavy personal and societal burden of SUDs, current treatments are limited and unsatisfactory. For this reason, a deeper understanding of the mechanisms underlying addiction is required. Altered redox status, primarily due to drug-induced increases in dopamine metabolism, is a unifying feature of abused substances. In recent years, knowledge of the effects of oxidative stress in the nervous system has evolved from strictly neurotoxic to include a more nuanced role in redox-sensitive signaling. More specifically, S-glutathionylation, a redox-sensitive post-translational modification, has been suggested to influence the response to drugs of abuse. In this review we will examine the evidence for redox-mediating drugs as therapeutic tools focusing on N-acetylcysteine as a treatment for cocaine addiction. We will conclude by suggesting future research directions that may further advance this field.

References

Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·B HopeE J Nestler
Sep 15, 1987·Biochemical Pharmacology·S M RobertsR C James
Mar 1, 1993·Behavior Genetics·H R ThomassonT K Li
Mar 5, 1996·Proceedings of the National Academy of Sciences of the United States of America·T G HastingsM J Zigmond
Jan 1, 1996·Annual Review of Biochemistry·O CouxA L Goldberg
Sep 1, 1996·Chemical Research in Toxicology·F CarvalhoM L Bastos
Sep 1, 1996·Neurochemical Research·M dos S Medeiros, A J Turner
May 13, 1997·Proceedings of the National Academy of Sciences of the United States of America·W W Wasserman, W E Fahl
Jun 1, 1997·Trends in Neurosciences·L A O'Neill, C Kaltschmidt
Jul 25, 1997·American Journal of Medical Genetics·D J VandenberghH M Lachman
Oct 6, 1997·Science·A I Leshner
May 23, 1998·Biochimica Et Biophysica Acta·J Smythies, L Galzigna
Dec 22, 1998·Brain Research. Brain Research Reviews·K C Berridge, T E Robinson
Apr 14, 1999·Cell Death and Differentiation·A G Porter, R U Jänicke
Jul 6, 2000·Progress in Neurobiology·R Dringen
Apr 25, 2001·Kidney International·J L MagnayA D Baines
Oct 31, 2001·The Journal of Biological Chemistry·J WangP B Chock
Dec 26, 2001·Brain Research. Brain Research Reviews·J G Liu, K J Anand
Mar 12, 2002·Methods in Enzymology·Peter Klatt, Santiago Lamas
Mar 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Maddalena FratelliPietro Ghezzi
Oct 22, 2002·The Journal of Pharmacology and Experimental Therapeutics·Zheng-Xiong XiPeter W Kalivas
Apr 3, 2003·The European Journal of Neuroscience·M Scott Bowers, Peter W Kalivas
May 13, 2003·Molecular Psychiatry·T M Tzschentke, W J Schmidt
May 20, 2003·Biological Chemistry·Ralf Dringen, Johannes Hirrlinger
Sep 3, 2003·Neuroscience Letters·Y IkegamiI Matsumoto
Dec 6, 2003·Addictive Behaviors·Peter N S Hoaken, Sherry H Stewart

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Related Papers

Progress in Molecular Biology and Translational Science
Jacqueline S Womersley, Joachim D Uys
Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Joachim D UysDanyelle M Townsend
Current Psychiatry Reports
Susan C McQuown, Marcelo A Wood
Advances in Experimental Medicine and Biology
Valentina SabinoPietro Cottone
Current Topics in Medicinal Chemistry
Wan ChenLuying Huang
© 2022 Meta ULC. All rights reserved